Mirae Asset Global ETFs Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.84M Sell
85,174
-4,778
-5% -$103K ﹤0.01% 1138
2025
Q1
$1.5M Buy
89,952
+6,303
+8% +$105K ﹤0.01% 1281
2024
Q4
$1.53M Sell
83,649
-3,256
-4% -$59.4K ﹤0.01% 1316
2024
Q3
$1.34M Buy
86,905
+3,768
+5% +$58.1K ﹤0.01% 1371
2024
Q2
$1.35M Buy
+83,137
New +$1.35M ﹤0.01% 1286